HOME OUR PRODUCTS PHARMA HEALTHCARE

Emtricitabine + Tenofovir Alafenamide Tablets

Emtricitabine 200mg and Tenofovir Alafenamide 25mg Tablets Exporters

* To be consumed as directed by physician.

Emtricitabine 200mg and Tenofovir Alafenamide 25mg Tablets

Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) Tablets
  • Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) is a film-coated, blue, rectangle shaped tablet debossed with GSI on one side and 225 on the other side of the tablet.
  • Two antiretroviral agents form the combination. The two drug combination of Emtricitabine (FTC) and Tenofovir Alafenamide (TAF) is called Descovy both agents are HIV nucleoside analog reverse transcriptase inhibitors (NRTIs).
  • The dose of Descovy is fixed and
  • FTC is a synthetic nucleoside analog of cytidine which is an HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI)
  • TAF is a HIV NRTI, and an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5 – monophosphate.
  • It treats the human immune deficiency type 1 (HIV – 1) infection in adults and pediatric patients 12 years of age and older.
  • Descovy treats pre-exposure prophylaxis and reduces the risk of HIV in adults and adolescents.
  • It reduces the risk of spreading the HIV through sex.
  • Descovy does not cure HIV - 1 but it treats/prevents the individual from being affected by AIDS.
  • Make sure you are HIV – negative while taking the Descovy tablet.
  • Do not miss, discontinue the doses of the tablet or the treatment will not effective and delayed.
  • Do not overlap any two doses, maintain regular time intervals between any two doses of the treatment
  • Tell your doctor about your medical history, allergic reactions, and the list of tablet that you are already using.
(4.5 Rating)

Product Enquiry

Send Message